DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.

MLA

Guo, Lei, et al. “DNA-Dependent Protein Kinase and Ataxia Telangiectasia Mutated (ATM) Promote Cell Survival in Response to NK314, a Topoisomerase IIα Inhibitor.” Molecular Pharmacology, vol. 80, no. 2, Aug. 2011, pp. 321–27. EBSCOhost, https://doi.org/10.1124/mol.109.057125.

APA

Guo, L., Liu, X., Jiang, Y., Nishikawa, K., & Plunkett, W. (2011). DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor. Molecular Pharmacology, 80(2), 321–327. https://doi.org/10.1124/mol.109.057125

Chicago

Guo, Lei, Xiaojun Liu, Yingjun Jiang, Kiyohiro Nishikawa, and William Plunkett. 2011. “DNA-Dependent Protein Kinase and Ataxia Telangiectasia Mutated (ATM) Promote Cell Survival in Response to NK314, a Topoisomerase IIα Inhibitor.” Molecular Pharmacology 80 (2): 321–27. doi:10.1124/mol.109.057125.